Adult Immunization Policy in Korea

키워드

참고문헌 (27)

1. Andre FE, "Vaccination greatly reduces disease, disability, death and inequity worldwide", Bull World Health Organ, 86, pp.140~146 (2008)
2. Lu CY, "Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries", Vaccine, 30, pp.2250~2255 (2012)
3. Sauer M, "Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low-and middle-income countries", Vaccine, 39, pp.1556~1564 (2021)
4. 정희진, "우리나라 성인에서 필요한 예방접종", 대한의사협회지, 54(12), pp.1289~1296 (2011), 대한의사협회
5. Choi WS, "Herpes zoster vaccine in Korea", Clin Exp Vaccine Res, 2, pp.92~96 (2013)
6. van Panhuis WG, "Contagious diseases in the United States from 1888 to the present", N Engl J Med, 369, pp.2152~2158 (2013)
7. McLaughlin JM, "Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013", J Prim Prev, 36, pp.259~273 (2015)
8. Thomas-Crusells J, "Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization", Vaccine, 30, pp.6007~6012 (2012)
9. 김미선, "Clinical Characteristics and Risk Factors for Severe Disease of Coronavirus Disease 2019 in a Low Case Fatality Rate Region in Korea", Infection and Chemotherapy, 53(4), pp.718~729 (2021), 대한감염학회[DOI]
10. 강승지, "Age-Related Morbidity and Mortality among Patients with COVID-19", Infection and Chemotherapy, 52(2), pp.154~164 (2020), 대한감염학회[DOI]
11. 최민주, "Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea", Journal of Korean Medical Science, 36(23), pp.1~13 (2021), 대한의학회[DOI]
12. Park Wan Beom, "COVID-19 Vaccination in Korea", Infection and Chemotherapy, 55(1), pp.135~149 (2023), 대한감염학회[DOI]
13. Mehta B, "Adult immunization : the need to address", Hum Vaccin Immunother, 10, pp.306~309 (2014)
14. Goronzy JJ, "Understanding immunosenescence to improve responses to vaccines", Nat Immunol, 14, pp.428~436 (2013)
15. Oxman MN, "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults", N Engl J Med, 352, pp.2271~2284 (2005)
16. Schmader KE, "Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years", Clin Infect Dis, 54, pp.922~928 (2012)
17. Lang PO, "Effectiveness of influenza vaccine in aging and older adults : comprehensive analysis of the evidence", Clin Interv Aging, 7, pp.55~64 (2012)
18. Dunkle LM, "PSC12 study team. Efficacy of recombinant influenza vaccine in adults 50 years of age or older", N Engl J Med, 376, pp.2427~2436 (2017)
19. DiazGranados CA, "Efficacy of high-dose versus standard-dose influenza vaccine in older adults", N Engl J Med, 371, pp.635~645 (2014)
20. Van Buynder PG, "The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine(TIV)in the elderly", Vaccine, 31, pp.6122~6128 (2013)
21. 이종구, "우리나라의 백신 정책", Infection and Chemotherapy, 40(1), pp.14~23 (2008), 대한감염학회
22. Korea Disease Control and Prevention Agency (KDCA), "Vaccination implementation standards and methods" (2023), KDCA
23. 윤재원, "The Korean Influenza National Immunization Program: History and Present Status", Infection and Chemotherapy, 49(4), pp.247~253 (2017), 대한감염학회
24. 허정연, "Vaccination Policy in Korean Armed Forces: Current Status and Future Challenge", Journal of Korean Medical Science, 30(4), pp.353~359 (2015), 대한의학회
25. "Adult immunization guideline"[URL]
26. Leidner AJ, "Cost-effectiveness of adult vaccinations : a systematic review", Vaccine, 37, pp.226~234 (2019)
27. "Vaccines Europe pipeline review dash board"[URL]

관련 논문AI추천